Verticals / Pharma, medtech & health distribution / Pharmacy & drug distribution
Pharmacy & drug distribution
8
Companies
with a public disclosure
3
Gave a number
a disclosed NPS
—
Median latest NPS
last 3 years
6
Silent
known companies, nothing published
Lighthouse companies
LucyRx
Pharmacy & drug distribution · lucyrx.com
65NPS · 2026
“LucyRx earned a Net Promoter Score of 65, reflecting strong customer feedback.”
Latest: biospace.com
Prime Therapeutics
Pharmacy & drug distribution · primetherapeutics.com
98NPS · 2025
“Prime Therapeutics' Sempre Health partnership initiative achieved a Net Promoter Score of 98 and increased medication adherence by 15 percentage points.”
Latest: healthcarefinancenews.com
NB
Non-Big Three PBMs
Pharmacy & drug distribution
4NPS · 2026
“Alternative PBM Net Promoter Score fell from +16 to +4, declining relative to Big Three PBMs; customer satisfaction metrics also declined.”
Latest: drugchannels.net
More companies
Number of entries in brackets.
Silent
Companies we know of in pharmacy & drug distribution that have published nothing on NPS or retention.
Fortune 500 #10
Fortune 500 #313
Pharmacy Benefit Manager
Pharmacy Services
Online Pharmacy
Pharmaceutical Packaging
About these figures
Every figure here was publicly disclosed by the named company: press releases, annual reports, SEC filings, earnings calls and news coverage. Companies tend to publish their NPS when it is good, so these numbers run higher than a true industry average: read them as what leading companies in this vertical say publicly, not as an industry benchmark.
NPS runs from −100 to +100. Retention figures are reported as the company defines them (net revenue retention, gross revenue retention, customer retention rate, churn). Every entry links to its source in the full database.